IP Library Granted Patent US 9,085,781
Granted Patent B2
US 9,085,781 · App. 13/947,338 · Granted Jul 21, 2015

Acetate resistance in yeast based on introduction of a mutant HAA1 allele

Inventors: Kenneth Zahn (Visalia, CA); Sandra Jacobson (Three Rivers, CA)
Assignee: Edeniq, Inc.
C12P7/06C07K14/395C12N1/22C12N15/81C12P7/10Y02E50/16Y02E50/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,085,781
App. No.
13/947,338
Granted
Jul 21, 2015
Kind
B2
Abstract

Improved haa1 transcriptional regulatory proteins, polynucleotides encoding improved haa1 transcriptional regulatory proteins and vectors and cells thereof are provided, as well as methods for converting a cellulose-containing biomass feedstock to ethanol using improved haa1 transcriptional regulatory proteins and cells expressing heterologous haa1 transcriptional regulatory proteins as disclosed herein.

Claims (22)

1. An isolated polynucleotide encoding a transcription factor polypeptide comprising an amino acid sequence that:

a. is at least 95% identical to amino acid sequence of SEQ ID NO:2; and

b. comprises at least one amino acid difference compared to SEQ ID NO:2 selected from the group consisting of F440Y, P518S, D508Y, N510K, A527V, I591V, H605Y, S622F, S639F, and S673L.

2. The isolated polynucleotide of claim 1 , wherein the amino acid sequence is at least 95% identical to SEQ ID NO:2.

3. The isolated polynucleotide of claim 2 , wherein the amino acid sequence comprises the following amino acid differences compared to SEQ ID NO:2: F440Y, P518S, I591V, H605Y, S622F, S639F, and S673L.

4. The isolated polynucleotide of claim 1 , wherein the polypeptide has a C-terminal deletion resulting in a polypeptide having fewer than 600 (e.g., fewer than 590, 580, 570, 560, 550) amino acids.

5. The isolated polynucleotide of claim 1 , wherein the amino acid sequence comprises the following amino acid differences compared to SEQ ID NO:2: D508Y, N510K, and A527V.

6. The isolated polynucleotide of claim 1 , wherein the amino acid sequence comprises at least two (e.g., 2, 3, 4, 5, 6, 7, or more) amino acid differences compared to SEQ ID NO:2 selected from the group consisting of F440Y, P518S, D508Y, N510K, A527V, I591V, H605Y, S622F, S639F, and S673L.

7. An expression cassette comprising a heterologous promoter operably linked to the polynucleotide of claim 1 .

8. The expression cassette of claim 7 , wherein the promoter is heterologous to the polynucleotide.

9. A yeast cell comprising the expression cassette of claim 7 , wherein the yeast cell ferments sugar in the presence of acetate with increased kinetics or increased fermentation-product titer than a control yeast cell lacking the expression cassette.

10. The yeast cell of claim 9 , wherein the yeast cell is a Saccharomyces cervisiae or Pichia stipitis cell.

11. The yeast cell of claim 10 , wherein the yeast cell lacks a wild type allele of HAA1.

12. The yeast cell of claim 10 comprising a genomically-integrated mutant haa1 allele replacing the wild type HAA1 allele.

13. The yeast cell of claim 10 comprising a mutant haa1 allele on a heterologous plasmid, wherein the cell also comprises a genomic wild type allele of HAA1.

14. The yeast cell of claim 9 exhibiting fermentation with increased kinetics or increased fermentation-product titer compared to a control yeast strain in the presence of 0.5% w/v or more acetate or 0.5% w/v or more acetic acid.

15. The yeast cell of claim 9 exhibiting fermentation with increased kinetics or increased fermentation-product titer compared to a control yeast strain in the presence of 0.8% w/v or more acetate or 0.8% w/v or more acetic acid.

16. A method of making ethanol from sugar, the method comprising contacting the yeast of claim 10 to a solution comprising sugar under conditions to allow for fermentation of the sugar into ethanol; and recovering the ethanol.

17. The method of claim 16 , wherein the solution comprises sufficient furfural to inhibit fermentation of a control yeast lacking the expression cassette.

18. An aqueous mixture comprising sugars, acetic acid and/or acetate and the yeast cell of claim 10 .

19. The mixture of claim 18 , wherein the mixture comprises at least 0.5% or at least 0.8% w/v acetic acid or acetate.

20. The mixture of claim 18 , wherein the mixture comprises cellulose-containing biomass.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2017
From: WESTERN ALLIANCE BANK (SUCCESSOR IN INTEREST TO BRIDGE BANK, NATIONAL ASSOCIATION)
To: EDENIQ, INC.
Reel/Frame 041815/0832 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 31, 2017
From: EDENIQ, INC.
To: TRINITY CAPITAL FUND II, L.P.
Reel/Frame 042125/0645 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Sep 6, 2016
From: EDENIQ, INC.
To: TRINITY CAPITAL FUND II, L.P., AS COLLATERAL AGENT
Reel/Frame 039918/0485 →
SECURITY INTEREST Recorded Mar 9, 2015
From: EDENIQ, INC.
To: BRIDGE BANK, NATIONAL ASSOCIATION
Reel/Frame 035120/0276 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2013
From: ZAHN, KENNETH; JACOBSON, SANDRA
To: EDENIQ, INC.
Reel/Frame 031685/0262 →
Continuity (2)
Provisional Application 61674676 · Jul 23, 2012
Related Publication 20140024095A1 · Jan 23, 2014